Lowe Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Lowe Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-126	Closed	-$9K	–	284
2019 Q2	$9K	Hold	126	–	–	0.01%	170
2019 Q1	$8K	Hold	126	–	–	﹤0.01%	158
2018 Q4	$8K	Hold	126	–	–	0.01%	147
2018 Q3	$10K	Hold	126	–	–	0.01%	149
2018 Q2	$9K	Hold	126	–	–	0.01%	147
2018 Q1	$9K	Hold	126	–	–	0.01%	158
2017 Q4	$9K	Hold	126	–	–	0.01%	163
2017 Q3	$10K	Hold	126	–	–	0.01%	153
2017 Q2	$9K	Hold	126	–	–	0.01%	135
2017 Q1	$9K	Hold	126	–	–	0.01%	136
2016 Q4	$9K	Hold	126	–	–	0.01%	139
2016 Q3	$10K	Hold	126	–	–	0.01%	141
2016 Q2	$11K	Hold	126	–	–	0.01%	130
2016 Q1	$12K	Hold	126	–	–	0.01%	119
2015 Q4	$13K	Hold	126	–	–	0.01%	117
2015 Q3	$12K	Hold	126	–	–	0.01%	118
2015 Q2	$15K	Buy	+126	New	+$13.8K	0.01%	118

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lowe Wealth Advisors's GILD Position: Q3 2019 in Review

Lowe Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 126 shares — an estimated $9K sold.

Lowe Wealth Advisors first reported a position in GILD in Q2 2015 and held it in 17 quarters. The position peaked at $15K in Q2 2015. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Lowe Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
Lowe Wealth Advisors sold 126 Gilead Sciences shares in Q3 2019, an estimated $9K.
Lowe Wealth Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 17 quarters.
Lowe Wealth Advisors's Gilead Sciences position peaked at $15K in Q2 2015.
1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Lowe Wealth Advisors's 13F filing for Q3 2019, filed 8 Oct 2019.